<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC5720689/results/search/disease/results.xml">
  <result pre="Sciences : Pharmacology : Drugs: Antipsychotics Migraine and risk of" exact="narcolepsy" post="in children: A nationwide longitudinal study Migraine and narcolepsy"/>
  <result pre="of narcolepsy in children: A nationwide longitudinal study Migraine and" exact="narcolepsy" post="in children Yang Chun-Pai Conceptualization Supervision Writing – original"/>
  <result pre="and source are credited. pone.0189231.pdf Abstract Background The association between" exact="migraine" post="and narcolepsy remains controversial. We aim to investigate whether"/>
  <result pre="are credited. pone.0189231.pdf Abstract Background The association between migraine and" exact="narcolepsy" post="remains controversial. We aim to investigate whether migraine is"/>
  <result pre="migraine and narcolepsy remains controversial. We aim to investigate whether" exact="migraine" post="is associated with an increased risk of developing narcolepsy"/>
  <result pre="whether migraine is associated with an increased risk of developing" exact="narcolepsy" post="in children. Methods In this longitudinal study, nationwide medical-claims"/>
  <result pre="longitudinal study, nationwide medical-claims data of pediatric patients (0-17y) with" exact="migraine" post="are identified using the National Health Insurance Research Database"/>
  <result pre="between 1997 and 2010 in Taiwan. Two cohorts are selected:" exact="migraine" post="cases (n = 8,923) and propensity score-matched non-migraine controls"/>
  <result pre="non-migraine controls (n = 35,692). Children with previous history of" exact="narcolepsy" post="or headache before the index date are excluded. Cohorts"/>
  <result pre="2012, their withdrawal from the NHI program, or incidence of" exact="narcolepsy" post="(ICD-9-CM: 347). Cox proportional hazards regression models are used"/>
  <result pre="estimate hazard ratios (HRs) and 95% confidence intervals of developing" exact="narcolepsy" post="in children with migraine compared to their non-migraine controls."/>
  <result pre="and 95% confidence intervals of developing narcolepsy in children with" exact="migraine" post="compared to their non-migraine controls. Results A total of"/>
  <result pre="non-migraine controls. Results A total of 13 incident cases with" exact="narcolepsy" post="are observed during follow-up, with incidence rates of 0.1915"/>
  <result pre="incidence rates of 0.1915 and 0.0278 per 1,000 person-years in" exact="migraine" post="and non-migraine children, respectively. After a mean follow-up period"/>
  <result pre="cohort, respectively, the former exhibited a greater risk of developing" exact="narcolepsy" post="compared to the latter (adjusted hazard ratio (aHR) ="/>
  <result pre="comorbidities and concurrent medication uptake, and in our analyses with" exact="migraine" post="subtypes. Conclusions Migraine is an independent risk factor for"/>
  <result pre="migraine subtypes. Conclusions Migraine is an independent risk factor for" exact="narcolepsy" post="development in children. Further studies are needed to validate"/>
  <result pre="our findings and to explore the exact pathophysiological mechanisms linking" exact="migraine" post="and narcolepsy. Funding This study is supported in part"/>
  <result pre="relevant data are within the paper. Introduction The association between" exact="migraine" post="and narcolepsy has been evaluated in several hospital-based studies"/>
  <result pre="are within the paper. Introduction The association between migraine and" exact="narcolepsy" post="has been evaluated in several hospital-based studies and still"/>
  <result pre="not allow us to firmly establish a causal relationship between" exact="migraine" post="and narcolepsy, or suggest a mechanism that could explain"/>
  <result pre="an increasing level of attention given on the development of" exact="narcolepsy" post="early in life [ 4]. Unfortunately, whether migraine is"/>
  <result pre="development of narcolepsy early in life [ 4]. Unfortunately, whether" exact="migraine" post="is associated with increased risk of narcolepsy in children"/>
  <result pre="4]. Unfortunately, whether migraine is associated with increased risk of" exact="narcolepsy" post="in children has not been explored in a large-scale"/>
  <result pre="networks [ 7]. The destruction of orexinergic system results in" exact="narcolepsy" post="as well as altered pain processing including migraine ["/>
  <result pre="results in narcolepsy as well as altered pain processing including" exact="migraine" post="[ 8]. Given that migraine may share with narcolepsy"/>
  <result pre="as altered pain processing including migraine [ 8]. Given that" exact="migraine" post="may share with narcolepsy in distinct brain areas especially"/>
  <result pre="including migraine [ 8]. Given that migraine may share with" exact="narcolepsy" post="in distinct brain areas especially in hypothalamus and neurotransmitter"/>
  <result pre="in hypothalamus and neurotransmitter systems or both, we hypothesize that" exact="migraine" post="can be linked to narcolepsy, particularly in children whose"/>
  <result pre="Taiwan National Health Insurance Research Database (NHIRD) to investigate whether" exact="migraine" post="is associated with an elevated risk of developing narcolepsy"/>
  <result pre="whether migraine is associated with an elevated risk of developing" exact="narcolepsy" post="in children less than 18 years of age. Materials"/>
  <result pre="years from the random, national-representative sample who have newly diagnosed" exact="migraine" post="between 1997 and 2010 (n = 38,284). We included"/>
  <result pre="and 2010 (n = 38,284). We included different types of" exact="migraine" post="including migraine with aura (ICD-9-CM: 346.0x), migraine without aura"/>
  <result pre="(n = 38,284). We included different types of migraine including" exact="migraine" post="with aura (ICD-9-CM: 346.0x), migraine without aura (ICD-9-CM: 346.1x)"/>
  <result pre="different types of migraine including migraine with aura (ICD-9-CM: 346.0x)," exact="migraine" post="without aura (ICD-9-CM: 346.1x) and unspecified migraine (ICD-9-CM: 346.9x)."/>
  <result pre="aura (ICD-9-CM: 346.0x), migraine without aura (ICD-9-CM: 346.1x) and unspecified" exact="migraine" post="(ICD-9-CM: 346.9x). For ascertainment of cases, any identified subject"/>
  <result pre="have at least two ambulatory care and/or inpatient visits with" exact="migraine" post="diagnosis during the study period. We excluded those diagnosed"/>
  <result pre="missing information regarding subject’s sex and birthday, their date of" exact="narcolepsy" post="diagnosis (n = 22,651), or those who had withdrawn"/>
  <result pre="or those who had withdrawn from the NHI program before" exact="migraine" post="diagnosis (n = 4,620) ( Fig 1). A sum"/>
  <result pre="Fig 1). A sum of 10,127 subjects resulted in the" exact="migraine" post="cohort. For these children, their first date of migraine"/>
  <result pre="the migraine cohort. For these children, their first date of" exact="migraine" post="diagnosis became their index date of observation. In a"/>
  <result pre="date of observation. In a similar manner, children without any" exact="migraine" post="diagnosis from the random sample were identified during the"/>
  <result pre="the comparison (non-migraine) cohort. They were subsequently propensity-score-matched with the" exact="migraine" post="children by age, sex, urbanization level, comorbidities, and index"/>
  <result pre="flowchart. Outcome variable Our primary outcome was the occurrence of" exact="narcolepsy" post="(ICD-9-CM: 347), defined as the initial outpatient visit or"/>
  <result pre="defined as the initial outpatient visit or hospital admission for" exact="narcolepsy" post="during the follow-up period. Both cohorts were followed up"/>
  <result pre="could potentially influence our outcome were also considered. They included" exact="schizophrenia" post="and organic psychosis (ICD-9-CM: 293–295), affective psychoses (ICD-9-CM: 296),"/>
  <result pre="psychoses (ICD-9-CM: 296), neurotic disorders (ICD-9-CM: 300), depression (ICD-9-CM: 311)," exact="learning disability" post="and developmental delay (ICD-9-CM: 315), mental retardation (ICD-9-CM: 317–319),"/>
  <result pre="retardation (ICD-9-CM: 317–319), central nervous system (CNS) infection (ICD-9-CM: 320–326)," exact="cerebral palsy" post="(ICD-9-CM: 342–344), cerebral vascular disorder (ICD-9-CM:430–438), head injury with"/>
  <result pre="(%). We compared baseline characteristics between children with and without" exact="migraine" post="using standardized mean difference (SMD). SMD of less than"/>
  <result pre="calculated for each cohort based on their incident events of" exact="narcolepsy" post="and were expressed as per 1,000 person-years. Using log-rank"/>
  <result pre="log-rank test, the statistical difference in the cumulative incidence of" exact="narcolepsy" post="between migraine and non-migraine cohorts was tested, and the"/>
  <result pre="the statistical difference in the cumulative incidence of narcolepsy between" exact="migraine" post="and non-migraine cohorts was tested, and the Kaplan-Meier method"/>
  <result pre="and their 95% confidence intervals (CIs) for the development of" exact="narcolepsy" post="in the study cohort compared to the matched comparison"/>
  <result pre="USA). Results After propensity-score matching, we selected 8,923 children with" exact="migraine" post="and 35,692 control children without migraine for analysis. Table"/>
  <result pre="selected 8,923 children with migraine and 35,692 control children without" exact="migraine" post="for analysis. Table 1 describes the baseline characteristics of"/>
  <result pre="the baseline characteristics of these identified subjects according to their" exact="migraine" post="status (yes or no). As expected, subjects from both"/>
  <result pre="and comorbidities. Mean age was 11.58±3.88 and 11.02±3.94 years for" exact="migraine" post="and non-migraine children, respectively, with a SMD of 0.145."/>
  <result pre="terms of baseline comorbidities and concurrent medication use, proportions of" exact="schizophrenia" post="and organic psychosis, affective psychoses, neurotic disorders, depression, learning"/>
  <result pre="of schizophrenia and organic psychosis, affective psychoses, neurotic disorders, depression," exact="learning disability" post="and developmental delay, mental retardation, CNS infection, cerebral palsy,"/>
  <result pre="depression, learning disability and developmental delay, mental retardation, CNS infection," exact="cerebral palsy," post="cerebral vascular disorder, head injury with skull fracture, vision"/>
  <result pre="of NSAIDs, ergotamine, acetaminophen, triptans and sedative-hypnotics are similar in" exact="migraine" post="and non-migraine subjects. Concomitant use of antiepileptics and antipsychotics,"/>
  <result pre="they were further adjusted for in the multivariate analyses. Among" exact="migraine" post="children, most belonged to the unspecified migraine type (71.75%,"/>
  <result pre="multivariate analyses. Among migraine children, most belonged to the unspecified" exact="migraine" post="type (71.75%, n = 6,402). As a part of"/>
  <result pre="such as hyperactivity, infectious diseases of the upper respiratory tract," exact="influenza" post="and epilepsy between our matched children. 10.1371/journal.pone.0189231.t001 Table 1"/>
  <result pre="hyperactivity, infectious diseases of the upper respiratory tract, influenza and" exact="epilepsy" post="between our matched children. 10.1371/journal.pone.0189231.t001 Table 1 Descriptive profile"/>
  <result pre="1049 11.76 Migraine without aura . . 1869 20.95 Unspecified" exact="migraine" post=". . 6402 71.75 Chi-Square Test a t-test SD:"/>
  <result pre="drugs A total of 13 subjects were newly diagnosed with" exact="narcolepsy" post="during the follow-up period, with incidence rates of 0.1915"/>
  <result pre="rates of 0.1915 and 0.0278 per 1,000 person-years in the" exact="migraine" post="and non-migraine cohorts, respectively. Table 2 displays results from"/>
  <result pre="(aHR: 5.30, 95% CI: 1.61, 17.4, p = 0.006) of" exact="narcolepsy" post="was observed in migraine children compared to non-migraine children."/>
  <result pre="1.61, 17.4, p = 0.006) of narcolepsy was observed in" exact="migraine" post="children compared to non-migraine children. The Kaplan-Meier survival curve"/>
  <result pre="curve with log-rank test also showed higher cumulative incidence of" exact="narcolepsy" post="in children with migraine (p = 0.0007) ( Fig"/>
  <result pre="also showed higher cumulative incidence of narcolepsy in children with" exact="migraine" post="(p = 0.0007) ( Fig 2). Fig 2 Cumulative"/>
  <result pre="= 0.0007) ( Fig 2). Fig 2 Cumulative incidence of" exact="narcolepsy" post="in children diagnosed with migraine versus children without migraine."/>
  <result pre="Fig 2 Cumulative incidence of narcolepsy in children diagnosed with" exact="migraine" post="versus children without migraine. (dotted line) Incidence of narcolepsy"/>
  <result pre="with migraine versus children without migraine. (dotted line) Incidence of" exact="narcolepsy" post="in children of the migraine cohort in the observation"/>
  <result pre="migraine. (dotted line) Incidence of narcolepsy in children of the" exact="migraine" post="cohort in the observation period. (solid line) Incidence of"/>
  <result pre="migraine cohort in the observation period. (solid line) Incidence of" exact="narcolepsy" post="in children of the non-migraine (reference) cohort. 10.1371/journal.pone.0189231.t002 Table"/>
  <result pre="Results from Cox proportional hazards model for the association between" exact="narcolepsy" post="and migraine in pediatric subjects (hazard ratios and 95%"/>
  <result pre="Cox proportional hazards model for the association between narcolepsy and" exact="migraine" post="in pediatric subjects (hazard ratios and 95% confidence intervals)."/>
  <result pre="proportional hazards regression. Stratified by sex, the incidence rates of" exact="narcolepsy" post="in girls and boys with migraine were 0.1382 and"/>
  <result pre="the incidence rates of narcolepsy in girls and boys with" exact="migraine" post="were 0.1382 and 0.2492 per 1,000 person-years, respectively; higher"/>
  <result pre="and 0.0268 per 1,000 person-years) ( Table 3). In addition," exact="migraine" post="boys showed 6.68-fold (95% CI: 1.17, 38.1, p&amp;lt;0.05) higher"/>
  <result pre="(95% CI: 1.17, 38.1, p&amp;lt;0.05) higher adjusted risk of developing" exact="narcolepsy" post="than the non-migraine cohort. Also observed with a statistically"/>
  <result pre="non-migraine cohort. Also observed with a statistically elevated risk of" exact="narcolepsy" post="were migraine children belonging to age group of 12–17"/>
  <result pre="Also observed with a statistically elevated risk of narcolepsy were" exact="migraine" post="children belonging to age group of 12–17 years old"/>
  <result pre="in cells for controls, we observed that there was higher" exact="narcolepsy" post="incidence in the migraine group compared to the non-migraine"/>
  <result pre="we observed that there was higher narcolepsy incidence in the" exact="migraine" post="group compared to the non-migraine group: 3 events in"/>
  <result pre="Furthermore, among children without any concurrent antiepileptic or antipsychotic uptake," exact="migraine" post="children were observed with statistically higher risk of narcolepsy:"/>
  <result pre="4 gives the results of our sensitivity analysis with different" exact="migraine" post="subtypes. The risk of narcolepsy is consistently higher in"/>
  <result pre="our sensitivity analysis with different migraine subtypes. The risk of" exact="narcolepsy" post="is consistently higher in the migraine children when compared"/>
  <result pre="subtypes. The risk of narcolepsy is consistently higher in the" exact="migraine" post="children when compared to non-migraine counterparts except for unspecified"/>
  <result pre="compared to non-migraine counterparts except for unspecified migraine: highest in" exact="migraine" post="with aura (aHR: 9.03, 95% CI: 2.34, 34.8, p&amp;lt;0.01),"/>
  <result pre="aura (aHR: 9.03, 95% CI: 2.34, 34.8, p&amp;lt;0.01), followed by" exact="migraine" post="without aura (aHR: 5.76, 95% CI: 1.48, 22.5, p&amp;lt;0.05)."/>
  <result pre="Table 3 Incidence rates, hazard ratios and confidence intervals of" exact="narcolepsy" post="for children patients with and without migraine stratified by"/>
  <result pre="confidence intervals of narcolepsy for children patients with and without" exact="migraine" post="stratified by demographic attribute, comorbidity and concomitant medication. Variables"/>
  <result pre="p&amp;lt;0.001 10.1371/journal.pone.0189231.t004 Table 4 Incidence rates and hazard ratios of" exact="narcolepsy" post="in different migraine subtypes. Migraine type Event no. Person-years"/>
  <result pre="4 Incidence rates and hazard ratios of narcolepsy in different" exact="migraine" post="subtypes. Migraine type Event no. Person-years Incidence rate per"/>
  <result pre="3 7821 0.38 7.39 (2.03–28.9) ** 5.76 (1.48–22.45) * Unspecified" exact="migraine" post="(346.9x) No 8 190672 0.04 1.00 (reference) 1.00 (reference)"/>
  <result pre="*** p&amp;lt;0.001 Discussion This nationwide, population-based cohort study demonstrated that" exact="migraine" post="in children less than 18 years of age was"/>
  <result pre="comorbidities and concurrent medication uptake. Furthermore, the elevated risk in" exact="migraine" post="children was consistently detected in migraine with aura and"/>
  <result pre="the elevated risk in migraine children was consistently detected in" exact="migraine" post="with aura and migraine without aura subtypes, indicating that"/>
  <result pre="migraine children was consistently detected in migraine with aura and" exact="migraine" post="without aura subtypes, indicating that the study results were"/>
  <result pre="influence of medical care-seeking behavior, thus reinforcing our conclusions that" exact="migraine" post="increased the risk of narcolepsy in children. Although not"/>
  <result pre="thus reinforcing our conclusions that migraine increased the risk of" exact="narcolepsy" post="in children. Although not many population-based estimates of narcolepsy"/>
  <result pre="of narcolepsy in children. Although not many population-based estimates of" exact="narcolepsy" post="in children are available, a European study has indicated"/>
  <result pre="further validated since a statistically significant higher hazard ratio of" exact="narcolepsy" post="is shown in the migraine children despite our comparatively"/>
  <result pre="significant higher hazard ratio of narcolepsy is shown in the" exact="migraine" post="children despite our comparatively higher observed incidence in the"/>
  <result pre="tract and influenza) or other illnesses such as hyperactivity and" exact="epilepsy" post="which could be capable of triggering narcolepsy onset were"/>
  <result pre="as hyperactivity and epilepsy which could be capable of triggering" exact="narcolepsy" post="onset were also found analogous between our two study"/>
  <result pre="two study cohorts, further confirming the relatively increased risk of" exact="narcolepsy" post="attributed to migraine. Still, even after controlled for the"/>
  <result pre="for the effects of other central nervous system conditions like" exact="schizophrenia" post="and organic psychosis, affective psychoses, neurotic disorders and others"/>
  <result pre="narcoleptic syndrome not confounded with idiopathic narcolepsy. The association between" exact="migraine" post="and narcolepsy was inconclusive. In the first hospital-based observational"/>
  <result pre="not confounded with idiopathic narcolepsy. The association between migraine and" exact="narcolepsy" post="was inconclusive. In the first hospital-based observational study, migraine"/>
  <result pre="and narcolepsy was inconclusive. In the first hospital-based observational study," exact="migraine" post="showed a 2-fold to 4-fold increase in patients with"/>
  <result pre="migraine showed a 2-fold to 4-fold increase in patients with" exact="narcolepsy" post="[ 2]. This data supported their previous findings that"/>
  <result pre="supported their previous findings that half of narcoleptic patients reported" exact="migraine" post="in a clinical sample. Nevertheless, a multi-centre case-control study"/>
  <result pre="96 narcoleptics did not find a significant higher prevalence of" exact="narcolepsy" post="with migraine [ 3]. In contrast to these small"/>
  <result pre="did not find a significant higher prevalence of narcolepsy with" exact="migraine" post="[ 3]. In contrast to these small sample size"/>
  <result pre="design, our study included a relatively large number of population-based" exact="migraine" post="pediatric cases, and a retrospective cohort study design with"/>
  <result pre="a sufficiently long follow-up period. Moreover, we focused on pediatric" exact="migraine" post="cases, not adults like those addressed in previous studies"/>
  <result pre="2, 3]. Thus, our results support the emerging notion that" exact="migraine" post="is associated with the risk of narcolepsy development in"/>
  <result pre="emerging notion that migraine is associated with the risk of" exact="narcolepsy" post="development in children. This association suggests a plausible pathophysiological"/>
  <result pre="needs to be further investigated. The exact pathophysiologic mechanisms linking" exact="migraine" post="and narcolepsy are unknown. Loss of orexinergic neurons in"/>
  <result pre="be further investigated. The exact pathophysiologic mechanisms linking migraine and" exact="narcolepsy" post="are unknown. Loss of orexinergic neurons in the hypothalamus"/>
  <result pre="the hypothalamus has been considered playing a causative role in" exact="narcolepsy" post="with cataplexy. There is evidence that dysfunctional hypothalamic activity"/>
  <result pre="cataplexy. There is evidence that dysfunctional hypothalamic activity contributes to" exact="narcolepsy" post="as well as altered pain processing via hypothalamic orexinergic"/>
  <result pre="has been demonstrated in functional and structural brain imaging for" exact="migraine" post="[ 12– 15]. On other aspects, hypothalamic orexinergic neurons"/>
  <result pre="hypothalamic orexinergic system is both involved in trigeminovascular nociception and" exact="narcolepsy" post="developing that predispose some patients to migraine and narcolepsy."/>
  <result pre="trigeminovascular nociception and narcolepsy developing that predispose some patients to" exact="migraine" post="and narcolepsy. Clinical evidence for the role of hypothalamic"/>
  <result pre="the role of hypothalamic orexinergic system in the modulation of" exact="migraine" post="has not yet clearly identified and warrants further research."/>
  <result pre="are associated with the present study. First, the diagnoses of" exact="migraine" post="and narcolepsy were entirely identified on the basis of"/>
  <result pre="with the present study. First, the diagnoses of migraine and" exact="narcolepsy" post="were entirely identified on the basis of ICD-9-CM codes,"/>
  <result pre="every contracted medical institution [ 16]. Ideally, the diagnosis of" exact="narcolepsy" post="should be based on the International Classification of Sleep"/>
  <result pre="(PSG). However, from our data, a lot of children with" exact="narcolepsy" post="may not be diagnosed with the ICSD-2 or -3"/>
  <result pre="disorder did not exhibit much medical attention previously. However, since" exact="narcolepsy" post="is a rare disease, with the diagnosis large restricted"/>
  <result pre="failsafe. Furthermore, since many clinicians were unfamiliar with this disorder," exact="narcolepsy" post="remained under-diagnosed, potentially leading to underestimation of the risk"/>
  <result pre="remained under-diagnosed, potentially leading to underestimation of the risk of" exact="narcolepsy" post="in the migraine cohort. Even so, there still exists"/>
  <result pre="leading to underestimation of the risk of narcolepsy in the" exact="migraine" post="cohort. Even so, there still exists the possibility that"/>
  <result pre="still exists the possibility that there are differential diagnoses of" exact="narcolepsy" post="in the pediatric population such as delayed circadian phase"/>
  <result pre="the pediatric population such as delayed circadian phase syndrome or" exact="attention deficit hyperactivity disorder." post="In addition, the diagnosis of migraine was validated previously"/>
  <result pre="or attention deficit hyperactivity disorder. In addition, the diagnosis of" exact="migraine" post="was validated previously [ 17]. Nevertheless, a more definite"/>
  <result pre="validated previously [ 17]. Nevertheless, a more definite diagnosis of" exact="migraine" post="as a primary neurological disorder (versus unspecified migraine; with"/>
  <result pre="Nevertheless, a more definite diagnosis of migraine as a primary" exact="neurological disorder" post="(versus unspecified migraine; with and without aura) is required"/>
  <result pre="and without aura) is required to solidify the association between" exact="migraine" post="and narcolepsy. Second, headache could potentially be a sign"/>
  <result pre="of results. Also, the frequency and severity of narcoleptic or" exact="migraine" post="symptoms could not be precisely extracted from ICD codes,"/>
  <result pre="codes, and this prevented further analysis. Third, patients in our" exact="migraine" post="cohort were considered &quot;active&quot; migraineurs. Patients whose migraine became"/>
  <result pre="in our migraine cohort were considered &quot;active&quot; migraineurs. Patients whose" exact="migraine" post="became inactive may have been excluded from the migraine"/>
  <result pre="whose migraine became inactive may have been excluded from the" exact="migraine" post="cohort and misclassified as controls. Under these conditions, the"/>
  <result pre="misclassified as controls. Under these conditions, the risk of developing" exact="narcolepsy" post="among patients with migraine might have been underestimated. Fourth,"/>
  <result pre="these conditions, the risk of developing narcolepsy among patients with" exact="migraine" post="might have been underestimated. Fourth, the NHIRD is an"/>
  <result pre="a result, our results merely showed the increased associations of" exact="narcolepsy" post="in patients with migraine, which may not allow a"/>
  <result pre="further confirmed. Conclusion This population-based longitudinal study provides evidence that" exact="migraine" post="diagnosis is associated with an increased risk of narcolepsy"/>
  <result pre="that migraine diagnosis is associated with an increased risk of" exact="narcolepsy" post="in children. The higher narcolepsy incidence in the pediatric"/>
  <result pre="with an increased risk of narcolepsy in children. The higher" exact="narcolepsy" post="incidence in the pediatric migraine population may indicate a"/>
  <result pre="narcolepsy in children. The higher narcolepsy incidence in the pediatric" exact="migraine" post="population may indicate a common pathway of pathophysiology relevant"/>
  <result pre="research is warranted to describe the exact pathophysiological mechanisms linking" exact="migraine" post="and narcolepsy. Public health relevance The association between migraine"/>
  <result pre="linking migraine and narcolepsy. Public health relevance The association between" exact="migraine" post="and narcolepsy in children has not been explored in"/>
  <result pre="and narcolepsy. Public health relevance The association between migraine and" exact="narcolepsy" post="in children has not been explored in a large-scale"/>
  <result pre="explored in a large-scale longitudinal study. As almost one-third of" exact="migraine" post="patients become symptomatic before reaching the age of 15,"/>
  <result pre="an increasing level of attention given on the development of" exact="narcolepsy" post="early in life. Using a nationwide population-based study approach,"/>
  <result pre="population-based study approach, our results support the emerging notion that" exact="migraine" post="is associated with the risk of developing narcolepsy in"/>
  <result pre="notion that migraine is associated with the risk of developing" exact="narcolepsy" post="in children. This derived association suggests a plausible pathophysiological"/>
  <result pre=", Grü B and Bierbrauer J . Increased frequency of" exact="migraine" post="in narcoleptic patients. Neurology . 1999; 52: 1291– 1293."/>
  <result pre=", Epplen JT and Ullrich B . Increased frequency of" exact="migraine" post="in narcoleptic patients: a confirmatory study. Cephalalgia . 2003;"/>
  <result pre="C , Hviid A , et al. The incidence of" exact="narcolepsy" post="in Europe: before, during, and after the influenza A(H1N1)pdm09"/>
  <result pre="incidence of narcolepsy in Europe: before, during, and after the" exact="influenza" post="A(H1N1)pdm09 pandemic and vaccination campaigns . Vaccine . 2013;"/>
  <result pre=", et al. Diagnosis and development of screening items for" exact="migraine" post="in neurological practice in Taiwan . J Formos Med"/>
 </snippets>
</snippetsTree>
